English | Español
Patient Daily | Mar 16, 2026

AbbVie reports early trial results for weight loss drug ABBV-295
Patient Daily | Mar 16, 2026

Hansoh reports positive Phase 3 results for obesity drug olatorepatide in China
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech
Patient Daily | Mar 16, 2026

Roche reports breast cancer drug giredestrant fails key Phase 3 trial
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
Patient Daily | Mar 16, 2026

Novo Nordisk to sell GLP-1 drugs through Hims & Hers after ending legal dispute
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
Patient Daily | Mar 16, 2026

Xenon to seek approval of first-in-class epilepsy drug after exceeding Phase 3 expectations

Trending
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Lilly reports late-stage diabetes data for triple-G agonist retatrutide
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

AstraZeneca announces Shanghai cell therapy manufacturing base to support China strategy